Abstract:Ochratoxin A (OTA) is a nephrotoxic and cancerogenic mycotoxin. There is epidemiological evidence that OTA exposition leads to cortical interstitial nephropathies in humans. However, virtually no data are available investigating the effect of OTA on renal cortical cells with respect to induction of nephropathy. Thus, we investigated whether OTA is able to induce changes of cellular properties potentially leading to interstitial nephropathy, using proximal tubular cell lines (OK, NRK-52E). OTA decreased cell nu… Show more
“…Some other studies also confirmed OTAinduced MAPK phosphorylation (5,24,25,28). Phosphorylation of ERK1/2 and of their substrates Elk-1 and p90RSK was observed in kidney samples of male Fischer 344 rats fed with a carcinogenic dose of OTA over 7 days, 21 days, and 12 months (24).…”
Section: Close Interplay Between Ota and Mapksmentioning
confidence: 66%
“…According to the European survey conducted by Miraglia et al (2), mean plasma concentration of OTA in adults is 0.875 nmol L -1 , and ranges from 0.53 nmol L -1 to 2.75 nmol L -1 . OTA half-life in serum ranges from 120 h in rats to 840 h in monkeys and humans (4,5). This prolonged retention in serum is the consequence of strong binding to serum proteins, mainly to albumin.…”
Section: Ochratoxin A: a Hazardous Mycotoxinmentioning
confidence: 99%
“…As OTA inhibits protein synthesis at relatively high doses, which are not seen in everyday exposure, these effects have only a minor toxicological relevance. However, Gekle et al (5) have suggested that in the low-dose range (naturally occurring exposure) OTA interacts with key cell targets, changing the signalling pathways. These changes affect the cell function, and may disturb the whole-organism homeostasis.…”
Section: Ochratoxin A: a Hazardous Mycotoxinmentioning
confidence: 99%
“…In most cases, high OTA concentrations (>1 μmol L -1 ) cause necrosis of renal cells (both of proximal tubular and collecting duct origin), as demonstrated by lactate dehydrogenase (LDH) release (5,49). In contrast, at low nanomolar concentrations, OTA stimulates apoptosis, which has been confi rmed by chromatin condensation and fragmentation (DAPI staining, haematoxylin/eosin staining), DNA fragmentation (TUNEL assay, diphenylamine method), DNA ladder formation (DNA electrophoresis on agarose gel), and/or apoptotic enzyme caspase-3 activation (5,26,28,50). In addition, at 1 μmol L -1 , OTA was associated with both types of cell death (5,26,28).…”
Section: Close Interplay Between Ota and Mapksmentioning
confidence: 99%
“…In contrast, at low nanomolar concentrations, OTA stimulates apoptosis, which has been confi rmed by chromatin condensation and fragmentation (DAPI staining, haematoxylin/eosin staining), DNA fragmentation (TUNEL assay, diphenylamine method), DNA ladder formation (DNA electrophoresis on agarose gel), and/or apoptotic enzyme caspase-3 activation (5,26,28,50). In addition, at 1 μmol L -1 , OTA was associated with both types of cell death (5,26,28). These effects also appear to be cell-specifi c, which might explain why certain epithelial cell types along the nephron differ in susceptibility to OTA.…”
Section: Close Interplay Between Ota and Mapksmentioning
A Journey Through Mitogen-Activated Protein Kinase and Ochratoxin A InteractionsOchratoxin A (OTA) is a ubiquitous mycotoxin with potential nephrotoxic, carcinogenic, and cytotoxic action. It has been proposed that OTA might be involved in the development of Balkan endemic nephropathy, which is associated with an increased risk of urinary tract tumours, and of other forms of interstitial nephritis. Cell susceptibility to OTA mainly depends on mycotoxin concentrations, duration of exposure, and intracellular molecular and genetic context. OTA can affect a cell by stimulating or inhibiting certain signalling pathways such as mitogen-activated protein kinase (MAPK). Three major mammalian MAPKs have been described: extracellular signal-regulated protein kinase (ERK), c-Jun N-terminal kinase (JNK), and p38 MAPK. All MAPKs regulate diverse cellular programmes, but in most cases ERKs have been linked to cell survival, while JNKs, and p38 MAPKs have been implicated in cell death by apoptosis. This review looks into OTA-mediated MAPK activation and its effects.
“…Some other studies also confirmed OTAinduced MAPK phosphorylation (5,24,25,28). Phosphorylation of ERK1/2 and of their substrates Elk-1 and p90RSK was observed in kidney samples of male Fischer 344 rats fed with a carcinogenic dose of OTA over 7 days, 21 days, and 12 months (24).…”
Section: Close Interplay Between Ota and Mapksmentioning
confidence: 66%
“…According to the European survey conducted by Miraglia et al (2), mean plasma concentration of OTA in adults is 0.875 nmol L -1 , and ranges from 0.53 nmol L -1 to 2.75 nmol L -1 . OTA half-life in serum ranges from 120 h in rats to 840 h in monkeys and humans (4,5). This prolonged retention in serum is the consequence of strong binding to serum proteins, mainly to albumin.…”
Section: Ochratoxin A: a Hazardous Mycotoxinmentioning
confidence: 99%
“…As OTA inhibits protein synthesis at relatively high doses, which are not seen in everyday exposure, these effects have only a minor toxicological relevance. However, Gekle et al (5) have suggested that in the low-dose range (naturally occurring exposure) OTA interacts with key cell targets, changing the signalling pathways. These changes affect the cell function, and may disturb the whole-organism homeostasis.…”
Section: Ochratoxin A: a Hazardous Mycotoxinmentioning
confidence: 99%
“…In most cases, high OTA concentrations (>1 μmol L -1 ) cause necrosis of renal cells (both of proximal tubular and collecting duct origin), as demonstrated by lactate dehydrogenase (LDH) release (5,49). In contrast, at low nanomolar concentrations, OTA stimulates apoptosis, which has been confi rmed by chromatin condensation and fragmentation (DAPI staining, haematoxylin/eosin staining), DNA fragmentation (TUNEL assay, diphenylamine method), DNA ladder formation (DNA electrophoresis on agarose gel), and/or apoptotic enzyme caspase-3 activation (5,26,28,50). In addition, at 1 μmol L -1 , OTA was associated with both types of cell death (5,26,28).…”
Section: Close Interplay Between Ota and Mapksmentioning
confidence: 99%
“…In contrast, at low nanomolar concentrations, OTA stimulates apoptosis, which has been confi rmed by chromatin condensation and fragmentation (DAPI staining, haematoxylin/eosin staining), DNA fragmentation (TUNEL assay, diphenylamine method), DNA ladder formation (DNA electrophoresis on agarose gel), and/or apoptotic enzyme caspase-3 activation (5,26,28,50). In addition, at 1 μmol L -1 , OTA was associated with both types of cell death (5,26,28). These effects also appear to be cell-specifi c, which might explain why certain epithelial cell types along the nephron differ in susceptibility to OTA.…”
Section: Close Interplay Between Ota and Mapksmentioning
A Journey Through Mitogen-Activated Protein Kinase and Ochratoxin A InteractionsOchratoxin A (OTA) is a ubiquitous mycotoxin with potential nephrotoxic, carcinogenic, and cytotoxic action. It has been proposed that OTA might be involved in the development of Balkan endemic nephropathy, which is associated with an increased risk of urinary tract tumours, and of other forms of interstitial nephritis. Cell susceptibility to OTA mainly depends on mycotoxin concentrations, duration of exposure, and intracellular molecular and genetic context. OTA can affect a cell by stimulating or inhibiting certain signalling pathways such as mitogen-activated protein kinase (MAPK). Three major mammalian MAPKs have been described: extracellular signal-regulated protein kinase (ERK), c-Jun N-terminal kinase (JNK), and p38 MAPK. All MAPKs regulate diverse cellular programmes, but in most cases ERKs have been linked to cell survival, while JNKs, and p38 MAPKs have been implicated in cell death by apoptosis. This review looks into OTA-mediated MAPK activation and its effects.
Ochratoxin A (OTA) is a ubiquitous fungal metabolite with nephrotoxic, carcinogenic, and apoptotic potential. Toxicokinetics make the kidney the primary target organ for OTA. Due to its widespread occurrence in improperly stored foodstuff the complete and safe avoidance of OTA for humans is impossible. There are several reports showing a significant correlation between OTA exposure and certain forms of nephropathies. At nanomolar concentrations OTA leads to specific changes of function and phenotype in renal cells. The toxin interacts with certain cellular "key-molecules" (e. g., mitogen-activated protein (MAP) kinases, Ca2+), thereby disturbing cellular signalling and regulation events as well as mitochondrial function. Moreover, OTA has the ability to modulate physiological signals (e. g., angiotensin II or TNFalpha) and thereby influences cell function and cell growth and may even stable re-program the cells (e. g., altered distribution of chromosomes). This review concentrates on the effects of OTA in the nanomolar range and its interactions with cellular signalling networks in different renal cells proposing OTA to act as a signal modulator.
Ochratoxin A (OTA) is a ubiquitous mycotoxin produced by fungi of improperly stored food products. OTA is nephrotoxic and is suspected of being the main etiological agent responsible for human Balkan endemic nephropathy (BEN) and associated urinary tract tumours. Striking similarities between OTA-induced porcine nephropathy in pigs and BEN in humans are observed. International Agency for Research on Cancer (IARC) has classified OTA as a possible human carcinogen (group 2B). Currently, the mode of carcinogenic action by OTA is unknown. OTA is genotoxic following oxidative metabolism. This activity is thought to play a central role in OTA-mediated carcinogenesis and may be divided into direct (covalent DNA adduction) and indirect (oxidative DNA damage) mechanisms of action. Evidence for a direct mode of genotoxicity has been derived from the sensitive 32P-postlabelling assay. OTA facilitates guanine-specific DNA adducts in vitro and in rat and pig kidney orally dosed, one adduct comigrates with a synthetic carbon (C)-bonded C8-dG OTA adduct standard. In this paper, our current understanding of OTA toxicity and carcinogenicity are reviewed. The available evidence suggests that OTA is a genotoxic carcinogen by induction of oxidative DNA lesions coupled with direct DNA adducts via quinone formation. This mechanism of action should be used to establish acceptable intake levels of OTA from human food sources.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.